drugset / Trial / NCT01601093
Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
RandomizedFactorialSingle-blindTreatment
Summary
In the proposed study, the investigators plan to evaluate the efficacy and safety of Ceftazidime Sodium and Sulbactam Sodium for Injection(2:1) for the treatment of respiratory and urinary tract acute bacterial infection.
Timeline
- Start
- 2011-11
- Primary completion
- 2022-08-15
- Completion
- 2022-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cefoperazone | Small molecule | 2 g | Intravenous |
| Subject | Ceftazidime | Small molecule | 2 g | Intravenous |
| Subject | Ceftazidime | Small molecule | 3 g | Intravenous |
| Subject | Sulbactam | Small molecule | 1 g | Intravenous |
| Subject | Sulbactam | Small molecule | 1.5 g | Intravenous |